Benralizumab injection pen used to treat severe eosinophilic asthma
Contains benralizumab 30mg, a biologic that depletes eosinophils, a type of white blood cell driving inflammation in certain asthma types, used as an add-on treatment for severe eosinophilic asthma.
Attributes
Product Content
How to Use:
• Administered only by a doctor or nurse by subcutaneous injection, every 4 weeks then every 8 weeks.
• Continue your regular asthma medicines unless your doctor advises otherwise.
• Report worsening asthma symptoms to your doctor.
• Prescription medicine; take exactly as prescribed and consult your doctor before use.
The link to Fasenra Pen 30mg/ml 1 Prefilled Pen (Refregirated) has been copied